| Amgros 2027 1.1492.a | Amgros I/S | Accord Healthcare AB, Recordati AB, Recordati AB | 807.275.236 kr. | 10. november 2026 |
| Amgros 2027 1.1493.a | Amgros I/S | AstraZeneca A/S, AstraZeneca A/S, Institut Produits Synthése (IPSEN) AB, Orifarm A/S, Institut Produits Synthése (IPSEN) AB, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Accord Healthcare AB | 196.584.887 kr. | 10. november 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 1.1052.b | Amgros I/S | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, Abacus Medicine A/S, 2care4 ApS | 704.000.000 kr. | 21. september 2026 |
| Amgros 2026 1.630.b | Amgros I/S | Zentiva Denmark ApS, Medical Valley Invest AB, Zentiva Denmark ApS, Viatris ApS, Accord Healthcare AB, Merz Therapeutics Nordics AB | 130.570.241 kr. | 10. september 2026 |